논문 상세보기

Cordycepin suppresses expression of pro-inflammatory mediators in lipopolysaccharide-stimulated BV2 microglia KCI 등재

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/276390
모든 회원에게 무료로 제공됩니다.
한국버섯학회지 (Journal of Mushrooms (J. Mushrooms))
한국버섯학회 (The Korean Society of Mushroom Science)
초록

[Background] Cordyceps militaris, a traditional medicinal mushroom, produces a component compound, cordycepin (3’-deoxyadenosine). Cordycepin has been known to have many pharmacological activities including immunological stimulating, anti-cancer, and anti-infection activities. However, the molecular mechanisms of inflammatory mediator’s activity by cordycepin remain poorly understood. In the present study, we investigat-ed the effects of cordycepin on the anti- inflammation cascades in lipopolysaccharide (LPS)-stimulated BV2 microglia cells. [Methods] Cordycepin were administered and their effects on LPS-induced pro-inflammatory mediators and MAP kinases were monitored by Western blotting and RT-PCR analysis. [Result] Cordycepin significantly inhibited the production of nitric oxide (NO), prostaglandin E2 (PGE2), and pro- inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α in a concentration- dependent manner without causing cytotoxicity. Also, cordycepin suppressed inducible NO, synthase (iNOS) and cyclooxygenase-2 (COX-2) expression on the mRNA and protein level. In addition, cordycepin suppressed NF-κB translocation by blocking IkappaB- α (IκB-α) degradation and inhibited the phosphorylation of Akt, ERK-1/2, JNK, and p38 kinase. Our results indicate that the inhibitory effect of cordycepin on LPS -stimulated inflammatory mediator production in BV2 microglia is associated with the suppression of the NF-κB, Akt, and MAPK signaling pathways. Conclusion: Anti-inflammatory properties of cordycepin may be useful for treating the inflammatory and deleterious effects of microglial activation in response to LPS stimulation.

저자
  • Jin-Woo Jeong(Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, Republic of Korea)
  • Seong-Sook Park( Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, Republic of Korea) | Seong-Sook Park
  • Yung-Hyun Choi( Department of Biomaterial Control (BK21 program), Dongeui University Graduate School, Busan 614-714, Republic of Korea Department of Biochemistry and Research Institute of Oriental Medicine, Dongeui University College of Oriental Medicine, Busan 614-052, Republic of Korea) | Yung-Hyun Choi
  • Jae-Dong Lee( Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, Republic of Korea) | Jae-Dong Lee